Provider
Empaveli (pegcetacoplan) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Feb 01, 2025
Search Results
Displaying 2031 - 2040 of 3795 results
Provider
Dojolvi - Medicaid
Prior Authorization
Program effective Date: Feb 01, 2025
Provider
QP3-22 Commercial Pharmacy Benefit Exclusion for Loreev XR and Sertraline Capsules
Program effective Date: Jan 12, 2022
Provider
QP4-22 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective March 1, 2022
Program effective Date: Jan 12, 2022
Provider
Dojolvi - Commercial
Prior Authorization
Program effective Date: Feb 01, 2025
Provider
Carbaglu (carglumic acid) - Medicaid
Prior Authorization
Program effective Date: Dec 01, 2024
Provider
Atypical Antipsychotics - Extended Maintenance Agents - Commercial
Step Therapy, Quantity Limit
Program effective Date: Jul 01, 2025
Provider
Atopic Dermatitis (Elidel [pimecrolimus], Eucrisa, tacrolimus) - Medicaid
Step Therapy
Program effective Date: Feb 01, 2025
Provider
Atopic Dermatitis (Elidel [pimecrolimus], Eucrisa, tacrolimus) - Commercial
Step Therapy
Program effective Date: Feb 01, 2025
Provider
Acute Migraine Agents - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Jun 01, 2025